| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 317,509 | 387,648 | 689,862 | 509,410 | | Cost of Revenue | 81,062 | 400,394 | 443,838 | 28,169 | | | Gross Profit | 236,447 | (12,746) | 246,024 | 481,241 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 189,022 | (75,158) | 94,773 | 347,527 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 46,903 | 47,727 | 48,522 | 49,591 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 522 | 14,685 | 102,729 | 84,123 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,971 | 2,452 | (1,704) | (8,834) | | Earnings Before Interest And Taxes | 4,493 | 17,137 | 101,025 | 75,289 | | Interest Expense | 21,229 | 20,716 | 20,523 | 22,581 | | Income Before Tax | (16,736) | (3,579) | 80,502 | 52,708 | | Income Tax Expense | (8,439) | (2,985) | 30,521 | 21,476 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,297) | (594) | 49,981 | 31,232 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,297) | (594) | 49,981 | 31,232 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,297) | ($594) | $49,981 | $31,232 |
|
0.10% Nasdaq 
Income Statement
